In-depth mechanistic understanding of novel macrophage-modulating anticancer compounds using state-of-the-art model systems.

Research unit

INNOSUISSE

Project number

128.411 INNO-LS

Project title

In-depth mechanistic understanding of novel macrophage-modulating anticancer compounds using state-of-the-art model systems.

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Biotechnology and processing
Abstract (English)	Abbmira and ZHAW are collaborating to advance Compound42, a drug designed to support the native immune system?s fight against cancer. ZHAW?s experiments using state-of-the art in vitro laboratory-models will generate critical data for guiding further drug-development and future clinical trials.